No Data
No Data
Southwest Securities: How to view the investment opportunities and challenges of high-value consumables in the post-medicine group purchase era?
In the context of centralized procurement, most areas in the high-value consumables field are currently highly competitive and have limited growth potential. Therefore, the tracks with low penetration rates and low localization rates have long-term growth potential.
Lepu Medical Technology (300003.SZ): Has repurchased 0.72% of its shares to date.
Lepu Medical Technology (300003.SZ) announced that as of July 31, 2024, the company has repurchased a total of 13,592,200 shares through a repurchase special securities account using centralized bidding trading method, accounting for 0.72% of the company's latest total share capital. The highest fill price was 16.65 yuan/share and the lowest fill price was 12.18 yuan/share with a total trading amount of 200.0816 million yuan (excluding transaction costs). The buyback is in compliance with the company's established buyback plan and relevant laws and regulations.
Lepu Medical Technology (300003.SZ) has repurchased a total of 0.72% of its shares.
Lepu Medical Technology (300003.SZ) announced on July 2nd that as of June 28, 2024, the company has repurchased 13,592,200 shares of its own stock through a designated securities account for centralized bidding transactions, accounting for 0.72% of the company's latest total share capital. The highest fill price is 16.65 yuan/share, the lowest fill price is 12.18 yuan/share, and the total transaction amount is 200.0816 million yuan (excluding transaction fees).
Where will Lepu Medical Technology go after the capital chess game of "frantic offensive"?
Seeking certainty in uncertainty. Lepu Medical Technology (stock code: 300003.SZ, hereinafter referred to as the 'Company') is splitting off its third subsidiary for listing in an uncertain environment. So far, the Company has split off and listed two subsidiaries. Both the Company and its peers are entering a period of weakness. The 'aggressive rush' during the years of capital operation, coupled with the uncertainty of future performance growth, has attracted more questions. In the current domestic medical equipment market, a more diverse picture is emerging. With the aftermath of the split-off listing and the rise of consumer medical technology, everyone is exploring their own path forward, standing at the crossroads of uncertainty.
Lepu Medical Technology (SZ 300003): Annual equity distribution of 10 shares and 3.314 yuan per share. Record date is June 26th, 2023.
Lepu Medical Technology (300003.SZ) announced on June 19th that the annual equity distribution plan for 2023 is as follows: based on the company's existing total share capital of 1,880,610,558 shares subtracted by 31,865,700 repurchased shares, the base number of shares is 1,848,744,858, and each shareholder will receive RMB 3.314100 in cash (including tax) for every 10 shares. The record date for this equity distribution is June 26, 2024, and the ex-right and ex-dividend date is June 27, 2024.
Two self-developed products from Lepu Medical (300003.SZ) subsidiary companies received NMPA registration approval
Lepu Medical (300003.SZ) announced that the company's subsidiary, Sichuan Xingtai Pule Medical Technology Co., Ltd. independently researched...
No Data